Cite
APA Citation
Taniguchi, H., Akagi, K., Dotsu, Y., Yamada, T., Ono, S., Imamura, E., Gyotoku, H., Takemoto, S., Yamaguchi, H., Sen, T., Yano, S., & Mukae, H. (2023). pan‐HER inhibitors overcome lorlatinib resistance caused by NRG1/HER3 activation in ALK‐rearranged lung cancer. Cancer science, 114(1), 164–173. http://access.bl.uk/ark:/81055/vdc_100173230788.0x000023